HCW Biologics Inc. (HCWB) IPO - S-1 Filing, Stock & Insider Activity
HCW Biologics Inc. IPO - Status & S-1 Filing
- Ticker: HCWB
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2026-01-09
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 7,691,124
- SEC CIK: 0001828673 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
HCW Biologics Inc. (HCWB) has filed 6 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-07-31. Insiders disclosed 9 open-market purchases totaling $530K. 12 Form 8-K material event filings were reported by HCWB in the last 90 days. InsiderAlpha tracks every HCWB SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About HCW Biologics Inc. (HCWB)
HCW Biologics Inc. trades under the ticker HCWB. InsiderAlpha tracks 8 primary SEC Form 4 filings from 4 reporting insiders for HCWB since 2025, sourced directly from SEC EDGAR.
| SEC CIK | 0001828673 |
|---|
90-Day SEC Filing Activity
| Insider purchases (90d) | 9 ($530K) |
|---|---|
| Form 4 filings (90d) | 6 |
| Form 8-K filings (90d) | 12 |
| Latest Form 4 filing | 2026-07-31 |
Recent HCWB Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Scott T. Garrett | Director | P - Open-market purchase | 7.7K | $2.58 | $20K | SEC | |
| Hing C. Wong | Chief Executive Officer | P - Open-market purchase | 23.2K | $2.58 | $60K | SEC | |
| Lee Flowers | SVP of Business Development | P - Open-market purchase | 7.7K | $2.58 | $20K | SEC | |
| Scott T. Garrett | Director | P - Open-market purchase | 177.9K | $1.41 | $250K | SEC | |
| Rebecca Byam | Chief Financial Officer | P - Open-market purchase | 14.2K | $1.41 | $20K | SEC | |
| Hing C. Wong | Chief Executive Officer | P - Open-market purchase | 113.9K | $1.41 | $160K | SEC | |
| Scott T. Garrett | Insider | P - Open-market purchase | 13.4K | $7.45 | $100K | SEC | |
| Scott T. Garrett | Insider | P - Open-market purchase | 5.4K | $26.00 | $140K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for HCW Biologics Inc. (HCWB). Updated in real time as new filings are submitted to the SEC.
Most-Active HCWB Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Scott T. Garrett | 3 | $270K |
| Hing C. Wong | 3 | $220K |
| Rebecca Byam | 2 | $20K |
| Lee Flowers | 1 | $20K |
Recent HCWB Form 8-K Material Events
- - Item 1.01, 3.02, 7.01, 8.01, 9.01 [SEC]
- - Item 8.01 [SEC]
- - Item 3.01, 9.01 [SEC]
- - Other · neutral [SEC]
Trading halt (T3) for HCWB. HCWB - - Other · neutral [SEC]
Trading halt (T1) for HCWB. HCWB
Recent Insider Filings
- - Hing C. Wong (Chief Executive Officer)
- - Lee Flowers (SVP of Business Development)
- - Scott T. Garrett (Director)
- - Hing C. Wong (Chief Executive Officer)
- - Scott T. Garrett (Director)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in HCWB insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
HCWB Insider Trading - FAQ
- What is the latest insider trade for HCWB?
- HCW Biologics Inc. (HCWB) had 6 insider filings in the last 90 days, with the most recent on 2026-07-31. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying HCWB stock?
- 9 insider purchases of HCWB were filed in the last 90 days, totaling $530K.
- How many insiders are selling HCWB stock?
- 0 insider sales of HCWB were filed in the last 90 days.
- Where can I see HCWB SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks HCWB Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $HFUS Hartford Creative Group, Inc.
- $HIFI Hillhouse Frontier Holdings Inc.
- $HIO WESTERN ASSET HIGH INCOME OPPORTUNITY FUND INC.
- $HKPD Cellyan Biotechnology Co., Ltd
- $HLXC Helix Acquisition Corp. III
- $HLYK HealthLynked Corp
- $HMH HMH Holding Inc
- $HNOI HNO International, Inc.
- $HONA Honeywell Aerospace Inc.
- $HQ Horizon Quantum Holdings Ltd.
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live HCWB dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.